Fifty-two year-old Paul McNeel, a fire chief from Leonardtown, Maryland was 37 in 1996 when a sudden health problem caused the loss of his small intestine. Almost all of it had to be surgically removed to save his life. For 13 years after that, McNeel continued to fight fires and stayed alive by feeding himself a special liquid formula through a tube that went from a port in his chest directly to his heart and into his bloodstream. Over time that feeding process called TPN or total parenteral nutrition took a toll on his body; it was damaging his liver and he began to suffer frequent and worsening infections. McNeel needed a life-saving transplant that 13 years earlier would not have been survivable. Thanks to research into improved surgical methods, better anti-rejection medications and a better understanding of the small intestine, McNeel was able to have that transplant in May 2009 at Georgetown University Hospital under the care of Thomas Fishbein, MD, executive director of the Georgetown Transplant Institute and a specialist in small bowel transplants.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52073-small-intestine-transplant-experts-hosted-by-georgetown
DOWNLOAD: https://soundcloud.com/dmvlife/shab-maze-grindin Shab
Maze Debuts His First Visual "Grindin" Off His Anticipated Debut
Mixtape Titled "Bottle Service" Which is set to drop late spring!For more info and updates follow on instagram ShabMaze Twitter RealShabMaze http://www.youtube.com/watch?v=pnaCF4SJwk8
Female board certified plastic surgeon Patti Flint MD offers information about her practice in Mesa and Scottsdale. http://www.pattiflintmd.com or http://www.lookingyourbest.com
Reed Street Productions, creators of the zombie-infested 5K adventure race, Run for Your Lives, announced today that the race will expand beyond its inaugural location outside of Baltimore into 12 cities across the country, starting with the Atlanta area on March 3, 2012. The inaugural race launched in Darlington, Md., last October with more than 10,000 participants and spectators.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54305-run-for-your-lives-zombie-5k-2012
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
With September marking National Prostate Cancer Awareness Month and the kick-off of the 2015 NFL season, the Urology Care Foundation and the NFL have renewed their commitment to driving prostate health awareness, as well as teamed up to highlight a Public Service Announcement (PSA) focused on educating men about prostate cancer and encouraging them to take charge of their health through the Know Your Stats® campaign.
The Know Your Stats® campaign is a rallying force to connect, educate and inspire men across the country to know their prostate cancer risk and talk to their doctor about whether prostate cancer testing is right for them.
“It is important for men to know their risk and talk to their doctors so they can determine if prostate cancer testing is right for them,” said Richard A. Memo, MD, Chair of the Urology Care Foundation. “Having the tools and facts empowers individuals and their doctors to make informed decisions.”
Prostate cancer is the second most common cancer in America, affecting one in seven men. Odds increase to one in five if they are African American and one in three if they have a family history; however, the educational tools are making an impact. More men are talking with their doctors and getting tested, and fewer men are dying from the disease.
To view the multimedia release go to:
http://www.multivu.com/players/English/7365551-prostate-cancer-know-your-stats-psa/
An audience of public relations and communications professionals gathered at the Getty Images Gallery in Central London for an interactive discussion into the increasingly important role content plays in communications and the relationship between brand and user. The evening also offered the opportunity for networking and the chance to enjoy the gallery’s spectacular Marilyn Monroe clothing and photographic exhibition.
Hosted by Andy Bowman of PR Newswire, the panel featured Adrian Barrick, CEO of UBM Built Environment, Jonathan Fildes, Editor of BBC Future at BBC Worldwide, Matthew Whalley, Technology Content Director at Edelman and Paul Wooding, MD Technology at Red.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56562-prnewswire-meet-the-media
At 90, Marjorie McFadden found herself unable to swallow. At Stanford Hospital & Clinics, she found innovative care that restored her ability to enjoy food again. Stanford digestive surgeon, Homero Rivas, MD, performed a per oral endoscopic myotomy, or POEM, to correct McFadden's achalasia, an unusual tightening of the muscles at the lower end of the esophagus. For McFadden's full story: http://stanfordhospital.org/newsEvents/newsletters/healthnotes/poem.html
Four-time PGA TOUR winner Tim Herron is teaming up with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), Damon Adamany, MD, of The CORE Institute and the Facts on Hand campaign to educate adults about one of the more common hand conditions. The campaign is raising awareness of Dupuytren’s Contracture, a progressive, potentially disfiguring hand condition affecting a layer of tissue underneath the palms that can cause one or more fingers to move into a bent position so they cannot be straightened.
Dupuytren’s Contracture, sometimes referred to as “Viking Disease,” can make everyday tasks difficult, such as grabbing an object at home, or in Tim Herron’s case, a nine iron from his golf bag. Many people live with the disease without being diagnosed because they mistakenly assume they have arthritis or another hand condition. And because Dupuytren’s Contracture may progress slowly, people may not pay attention to it until they can no longer straighten their fingers, complicating everyday activities.
To view the multimedia release go to:
https://www.multivu.com/players/English/8153851-endo-facts-on-hand-dupuytrens-contracture/
FedEx and ORBIS International, a leading global organization dedicated to saving sight worldwide, today kicked off a North American Goodwill Tour in Los Angeles, California with the announcement of a new $5.375 million commitment in the form of cash and in-kind gifts from FedEx. In addition, FedEx will donate an MD-10-30 cargo aircraft to ORBIS to be the third-generation Flying Eye Hospital. The Flying Eye Hospital will also visit Burlington, VT, Dallas/Fort Worth, TX, Memphis, TN, and Toronto and Ottawa, Canada between August and November to raise public awareness of the need to eliminate avoidable blindness.
To view Multimedia News Relwase, go to http://multivu.prnewswire.com/mnr/orbis/45157/
